Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway

Fig. 7

Suppression effect of ALO on tumor growth in vivo. A Representative tumors images of xenograft mice treated with ALO (30 mg/kg) or normal saline. B ALO group displayed a low weight of tumors compared to mock group. *P < 0.05, compared to the mock group (normal saline). C The tumors of ALO group showed a more slow growth compared to mock group. *P < 0.05, compared to the mock group (normal saline) at 21d; #P < 0.05, compared to the mock group (normal saline) at 28d. D WB images of representative tumors. Small part of xenograft tumor tissue was lysed with RIPA buffer. The tissue lysates were analyzed by Western blotting with the indicated antibodies. *P < 0.05, compared to the mock group (normal saline). Two-tailed Student’s test

Back to article page